Efter behandling med Siklos havde patienterne færre vaso- okklusive kriser end før behandlingen - mellem 66 og 80% færre hos børn og voksne.
Patients treated with Siklos had fewer vaso-occlusive crises after treatment with Siklos than before treatment, with the frequency falling by between 66% and 80% in children and adults.